| 1 |
33141329 | HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer. | 2021 Jan |
3 |
| 2 |
31745256 | Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer. | 2020 Jun |
1 |
| 3 |
32791030 | Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT. | 2020 Sep 1 |
1 |
| 4 |
30794306 | Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone. | 2019 Feb 1 |
5 |
| 5 |
29049492 | Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer. | 2018 Apr 1 |
3 |
| 6 |
29231195 | HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer. | 2018 Mar |
2 |
| 7 |
27575027 | HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study. | 2016 Oct |
4 |